Search

Introduction Mental illness has a large effect on sexual function and the expression of sexuality. Many studies have illustrated that sexual dysfunction is significantly associated with depression. Objectifs Assess the quality of sexual response in a population of depressed women. Search factors associated with impaired sexual function. Aims Investigate the degree of correlation between sexual dysfunction and depression. Methodes Analytical and descriptive Study involving 30 sexually active women seen for the first time at the Razi hospital. They presents a first major depressive episode according to DSM IV. Exclusion criteria were the presence of psychotic symptoms, the use of antidepressants in the last three months and inflammatory or neoplastic comorbidity. The severity of depression was assessed by the Beck Depression Scale. The evaluation of sexuality was made ??by Aziona sexual experience scale Results The middle-age was 37 years, 80% were married. Depression was severe in 60% of cases and the average time of care was 3.7 months. Sexual function was altered in 70% of cases with a positive correlation between the severity of depression, the depressive episode duration, and the sexual dysfunction. Sexual desire was the most affected by depression, distorted in more than half of patients. Sexual arousal and vaginal lubrication were also altered in respectively 40% and 36.7% of cases, while orgasm and satisfaction with orgasm were more conserved. Conclusion Taking into account the dimension of sexuality is important in the management of a depressive episode. Early treatment is a protective factor from sexual dysfunction in depressed women.

Background and Aims:Sexual dysfunction or difficulties(SDOD) exist in one-third of patients with untreated depressed outpatients with PTSD(posttraumatic stress disorder).SDOD manifested by decreased libido, erectile dysfunction or delayed ejaculation.Methods:This study investigated antidepressant activity and sexual functioning in depressed patients with PTSD taking mirtazapine. In our open-label study mirtazapine was administered for 6-10 weeks to 56 (11 women and 45 men) sexually active adult outpatients. Mirtazapine was titrated from 7,5 mg to 45 mg daily. Efficacy was assessed weekly by 21-item HAMD (Hamilton Depression Rating Scale). Sexual functioning was assessed weekly using Arizona Sexual Experiences Scale (ASEX), 5-item rating scale that quantifies sex drive, arousal, vaginal lubrication/penile erection, ability to reach orgasm, and satisfaction from orgasm.Results:In start of treatment individual HAMD scores were between 18 and 29, none of them experienced any sexual dysfunction prior to treatment.After 6 weeks of treatment, the individual HAMD scores were between 9 and 17, after 10 weeks HAMD scores were between 7 and 14, indicating significant improvement in depressive symptoms.None of the patients reported any sexual dysfunction symptoms. Five of the patients reported some unspecific sexsual difficulties and weight gain in three patient.Conclusions:treatment with mirtazapine was effective in both depressed women and men and no effect on sexual function.

Introduction Gender identity disorder is an emergent and important disorder which may lead to devastating consequences and comorbidities if proper treatment approaches are not used. Objectives We planned showing the improvements in patients’ life in multilple domains after sex reassignment surgery (SRS). Aims In our research we focused on changes experienced by people who gained new gender identity with sex reassignment surgery. Methods We interviewed at least one year after the operation with 20 sex reassigned transsexuals (SR-T) who were once on SRS programme of Istanbul University Psychiatry Department Psychoneurosis and Psychotherapy Unit and who had confirmative rapports for surgery and we also interviewed with 50 non-sex reassigned transsexuals (NSR-T) who applied to the same unit for SRS programme. Results Worries about gender discrimination and gender victimization were lower, but worries of being uncovered about transgender identity were higher in SR-T group. SR-T group scored lower on Family Assessment Device, 4th and 5th items of Arizona Sexual Life Scale and total points excluding the 3rd item (item for penile erection and vaginal lubrication), but scored higher on Multi Dimensional Scale for Perceived Social Support, Coopersmith Self Esteem Scale and psychological subscale of World Health Organization Quality of Life Scale-Brief Form. Conclusions The SRS used in the treatment of transsexuality releases the conflict and makes the transformation on official gender and is associated with improvements in quality of life, self esteem, family support, sexual life satisfaction and interpersonal reliationships and reduction in worries about gender discrimination and gender victimization.

Background Sexual dysfunction is the inability to perform satisfactory sexual activity. It is estimated that 80% of men have erectile dysfunction in dialysis and 55% of women, difficulty in sexual arousal. Men may have decreased libido, erectile dysfunction and difficulty reaching orgasm. Women have difficulty in sexual arousal, decreased vaginal lubrication, dyspareunia, and difficulty achieving orgasm. Objective Assess sexual dysfunction in hemodialysis patients. Methods A Cross-sectional analysis conducted with a randomized sample of 100 subjects from a total of 521 hemodialysis patients (20%) of both genders. Data were collected through Kidney Disease Quality of Life - Short Form (KDQOL-SF). Results Most patients were female (52%), mean age 55 ± 14 years. After KDQOL-SF, the most common complaint was lack of sexual activity (82.81%). Most patients are dissatisfied with sexual performance (59%). Among them, the more dissatisfied were women, 61% (36/59), p Conclusion There is evidence of high prevalence of dissatisfaction in the hemodialysis patients sexual performances. Further studies are needed on their sexual function, as well as therapeutic interventions that may offer improvement in this negative scenario.